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In the decade since the human genome sequence was declared complete, the develop-
ment of next generation sequencing (NGS) or “deep” sequencing to deliver cost-effective
genomic sequencing has influenced advances beyond its primary application and changed
the research landscape in many other areas. This review will survey recent applications of
NGS which have broadened the understanding of natural antibody repertoires (the “anti-
bodyome”) and how these evolve in response to viral infection.We will also report examples
where deep sequencing of binding populations, derived from both natural and synthetic
repertoires, have been used to benefit antibody engineering.This knowledge will ultimately
lead to the design of more effective biological drugs and vaccines.
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INTRODUCTION
Since the human genome was declared complete in April 2003,
the costs of genomic sequencing have been reduced by orders
of magnitude and available tools exist for data analysis, so that
access to massively parallel sequencing is no longer the exclusive
realm of large genome centers. Instead, next generation sequenc-
ing (NGS) technologies such as 454 pyrosequencing and Illumina
Solexa clonal bridge amplification methods have become wide-
spread and can be operated by individual investigators, allowing
the scope of their use to be expanded (1–7). In this review, we will
focus attention toward how NGS can reveal the sequence space
occupied by antibodies in their recognition of antigens. Specifi-
cally, we will concentrate on how NGS informs our knowledge of
natural antibody repertoires and how the humoral immune system
adapts to infection, how it can be used to improve the efficiency of
screening and how it can be applied to the design of new systems
for the discovery of novel biologics.
THE DEVELOPMENT OF NATURAL ANTIBODY REPERTOIRES
The sequencing of natural antibody or immunoglobulin (Ig)
repertoires poses a different challenge to genomic sequencing, as
the antibodyome (“the knowledge of the complete set of anti-
bodies in an individual”) is in constant flux whilst the genome
is relatively invariant. The diversity of the antibodyome in adult
humans is estimated from the numbers of antibody expressing B
cells within the body which is approximately 1010–1011. However,
this population changes quickly with time and tissue distribution,
resulting from daily turnover and replenishment of B cells, which
potentially introduces new sequences (8). This sequence multiplic-
ity is due to several natural mechanisms, the most important being
somatic recombination and rearrangement of two or three sets of
gene segments into a single unique gene. Each antibody is made of
the products of two genes, encoding heavy and light chains, which
provide further intricacy. In the case of the heavy chain gene, at
least 56 variable (V), 23 diversity (D), and 6 joining (J) segments
exist that are rearranged by RAG1 (recombination activating gene
1) and RAG2 recombinases in a process known as V(D)J recombi-
nation that brings VDJ segments together (light chain genes lack
D regions). Imprecise fusion at the junctions from insertions and
deletions through the activity of terminal deoxyribonucleotidyl
transferase creates additional combinatorial diversity (junctional
diversity) and the sequence from the V-D, through the D segment
to the D-J junction (or V-J junction in light chains) is known as
the complementarity determining region (CDR) 3 that is critical
for the antibody’s antigen specificity (9, 10).
Therefore, most of the effort to understand human antibody
repertoire has focused on deep sequencing of the CDR3 regions,
especially the heavy chain CDR-H3, to understand repertoire
diversity. The uniqueness of individual’s antibodyome was high-
lighted by results from sequencing these regions from two human
subjects, which discerned a slight bias in the pairing of D and
J but not in V-DJ. Also, between two individuals, there were
CDR-H3s in common although this was a small fraction of the
CDR-H3 diversity, estimated to be between 3 and 9× 109 (10).
Sequencing efforts have demonstrated that certain VH segments
are over-represented in the natural human repertoire but it was
uncertain whether this was determined by genetic, disease, age-
related, or environmental factors (11, 12). However, a study on
two monozygotic twin pairs demonstrated that whilst the varia-
tion in the naïve VH and DH segment use is strongly dictated by the
individual’s germline genetic background, even in the case where
one twin was affected by multiple sclerosis (MS), the CDR-H3
repertoires were highly specific to the individual. The authors sug-
gested that even with common gene segment profiles, there is likely
to be a different antibody response to common environmental
exposure (13).
Interestingly, in contrast to the CDR-H3 repertoire, recent
investigation in the rearrangement in the light chain CDR-L3
found that a surprisingly large proportion of CDR-L3 (more
than 20%) was shared across individuals, which indicates that an
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intrinsic genetic mechanism is responsible for maintaining those
sequences during human evolution (14).
Although the diversity of antibody repertoire is largely due
to V(D)J rearrangement, the immune response is mediated by
switching between Ig isotypes from IgM/IgD to the more specific
and effective isotypes IgA and IgG, important for efficient response
to infectious agents and induction of immune protection follow-
ing vaccination. The results of a study that monitored Ig-isotypes
from 14 healthy donors from different age groups and gender using
NGS showed that the V(D)J recombination pattern did not seem
to be affected by age, but there was a difference of isotype repre-
sentation between young adults and elderly donors who displayed
a reduction in class switch recombination (CSR) ability (15). This
is in agreement with reduced vaccination efficacy observed in the
elderly and was supported by an experiment in which the antibody
repertoire was sequenced before and after influenza vaccination
(16). It was found that older donors have fewer lineages; however,
their antibodies prior to vaccination had a higher level of muta-
tion. In a separate study of antibody classes and sequences derived
from the peripheral blood cells (PBCs) from six young and six old
donors, before and after influenza and pneumococcal vaccination,
no age-related differences were found for IgG except for a higher
mutation rate in the elderly and greater use of IgG2 (17). However,
the most striking difference was in the IgA response, mostly IgA1
(associated with serum response), that showed a reduced, slower,
clonal expansion. Both IgM and IgA had less hypermutations, but
larger CDR-H3 regions, which implies that there is a defect in the
mechanism of hypermutation in IgM and IgA that might affect
antigen recognition in the old.
Species with fewer B cells have been used as model systems
in an attempt to understand repertoire development. Zebrafish,
which has approximately 3× 105 antibody producing B cells, some
105-fold less than humans, were found to utilize between 50 and
86% of the 975 possible V(D)J combinations (18). Interestingly,
individual fish shared a small number of identical heavy chain
sequences. In a later article, it was shown that the earlyV(D)J reper-
toire between young fish was correlated due to antigen naivety
but developed greater diversification on maturity through somatic
hypermutation and antigen selection. The older fish had a higher
junctional diversity due to insertion and deletions from greater
expression of terminal deoxyribonucleotidyl transferase and the
repertoire shifted from one in which mutated sequences are mar-
ginally expressed to one where these were highly expressed (19).
As intimated from the later vaccination study of Jiang et al. above,
it is tempting to speculate that similar events occur within humans
as the immune system matures.
INSIGHTS INTO THE IMMUNE RESPONSE USING NGS
Understanding how the human humoral immune system responds
to infection is important for counteracting immune evasion and
to enlighten the development of effective vaccines and antibody-
based therapeutics. Recently, NGS has been used in this regard to
help understand the natural maturation of broadly neutralizing
antibodies (bnAbs) in HIV-1 infected individuals.
HIV-1 has evolved multiple mechanisms to evade the humoral
response and 10–25% of infected individuals develop cross-
reactive antibodies to a range of epitopes after several years of
infection. Changes in one such example of HIV-1 bnAbs,VRC01-
like antibodies, that recognize the CD4-binding site of HIV-1
gp120 have been followed by a combination of NGS and crys-
tallography (20). The mature VRC01 antibody is remarkable as
it develops over 70 mutations during the maturation process and
can neutralize approximately 90% of HIV-1 isolates. By study-
ing VRC01-like antibodies from patients, the authors observed
a maturation process that converged structures for optimizing
hydrophobic interactions that were precisely focused on an epitope
for the initial site of gp120-CD4 interaction. The convergence in
epitope recognition was accompanied by a divergence in antibody
sequence identity, including the occurrence of chemically conser-
vative changes in the paratopes and heavy chain revision or other
mechanisms of B cell diversification, as suggested by sequencing
of maturation intermediates (20). The heavy chains of the bnAbs
had also the potential for promiscuity in their light chain pairing,
but NGS could not elucidate the natural heavy and light chain
pairings (discussed below). In a separate study, variants of bnAb
10E8, which recognizes a helix-turn-helix motif in the membrane-
proximal external region of HIV-1 gp41, were identified with
somatic mutation levels as high as 28%. Phylogenetic trees created
from NGS and grid sampling were used to infer natural func-
tional heavy and light chain pairings, but mismatched pairings
led to greater autoreactivity (21). It is hypothesized that the high
degree of somatic mutations in the HIV-1 bnAbs is seen as a conse-
quence of an evasion strategy of HIV-1 where epitopes are poorly
recognized by germline antibodies and thus studies have been con-
ducted to identify appropriate intermediate and germline lineages
through NGS, phage screening, and phylogenetic analysis with the
hope of identifying better frameworks for antiviral bnAbs (22, 23).
In a similar investigation, peripheral blood mononuclear cells
(PBMCs) were isolated from a healthy individual following the
2009 H1N1 influenza pandemic (24). Five antibodies were iso-
lated as hybridomas that bound the Sa antigenic site of the globular
head of hemagglutinin and had a broader spectrum against H1N1
strains than the 2D1 neutralizing antibody cloned from a sur-
vivor of the 1918 H1N1 pandemic. The antibodies shared the same
heavy chain frameworks, VH3–7/JH6, but were derived from four
independent clones that showed convergence in CDR-H3 proper-
ties and conservation of some somatic mutations, demonstrating
an oligoclonal response against a viral antigen similar to those
observed against HIV-1. Using 454 pyrosequencing, clones could
still be identified, albeit rarely, in the peripheral blood of the donor
6 months after the initial blood draw for hybridoma generation.
However, the VH3-7/JH6 segments represented large circulating
phylogenies containing divergent unmutated germline sequences
as well as mutated clones, supporting the view that these may
assist in generating future immunological responses to the same or
similar antigens (24). Interestingly, a non-NGS study of antibody
responses to H1N1 infection used cell sorting, single cell RT-PCR,
and monoclonal antibody expression to identify bnAbs that recog-
nized the stalk or head domain of hemagglutinin. These antibodies
also contained a high degree of somatic mutations per sequence
(>19 on average) and a restricted VH usage suggesting maturation
and adaption to these epitopes on different influenza strains (25).
A study of New Zealand white rabbits immunized with hemo-
cyanin, similarly showed an oligoclonal serum response with 34
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antibodies grouping into 30 clonotypes likely to have been derived
from different progenitor B cells. The repertoire was dominated
by two to three VH and two JH families with a subpopulation
containing a large number of mutations. The VH response was
consistent with the abundances observed for the VH repertoire
highlighting the importance of the cellular repertoire in deter-
mining humoral immunity. Seven days post-immunization, 16
out of 34 of the identified CDR-H3s in the serum repertoire
map exclusively to sequences found in the PBC database, and
may be derived from recently activated plasma blasts in tran-
sit to the bone marrow, whereas the remainder were likely to be
expressed from plasma cells that had migrated to the bone mar-
row. There was also evidence of oxidative modification from mass
spectrometry but it was not known if this was an in vivo post-
translational modification contributing to additional diversity in
the antibody libraries (26). In another analysis of B cell distribu-
tion, the repertoire was compared on both sides of the blood-brain
barrier (BBB) in MS and patients suffering other neurological dis-
eases. In some patients, common VH sequences were identified on
both sides of the BBB, but the data indicated that only a few B
cells migrate through the BBB are retained in the central nervous
system (CNS). In MS patients the IGHV4 segment predominates,
suggesting the framework to be particularly suited against MS
antigens (27).
OVERCOMING THE LIMITATIONS OF NGS IN ANTIBODY
REPERTOIRE ANALYSIS AND ITS UTILITY IN SCREENING
As highlighted in the examples above, a deficiency of NGS is that
it is not currently possible to sequence both of the two chains of
the antibody in a single read. Therefore, when using the common
methods, no information on the natural VH:VL pairing, which
is crucial to discern native antibodies, can be obtained beyond
inference from frequency analysis of sequencing separately both
variable domains. However, despite this limitation, 21/27 scFvs
constructed from pairing together the most abundant VH and VL
genes from immunized mice were expressed in E. coli and bound
antigen with nanomolar affinity. Yet, pairing differently ranked
heavy and light variable domains in a full antibody format yielded
a subnanomolar IgG in HEK 293F cells (28). Indeed, the method
of repertoire mining of VH and VL abundances through NGS of
splenocytes, isolated from immunized mice, was compared with a
phage panning approach of the same cDNA. While both methods
provided antibodies with comparable affinities, clones identified
by repertoire mining showed higher selectivity for the antigen.
Antibodies selected by phage display were barely detected by NGS,
and conversely, mining the V repertoire identified antigen-specific
antibodies that were not selected by phage display (29). This study
demonstrated the expression bias of traditional phage display
methods and the complementarity of using both approaches to
isolate both rare and abundant binding sequences, thus support-
ing results from an earlier study by Ravn et al. (30). Here, NGS
data were used to retrieve scFvs that could bind to the target with
high affinity without the need for primary screening. Indeed the
methods enabled the retention of clones that could have been
lost during screening in small-scale soluble expression formats. A
similar method has been used for screening an antigen in a more
complex environment, where the antigen was not purified but
displayed on the bacterial surface. NGS analysis of a scFv library
that bound to bacterial cells expressing the target, versus a con-
trol population, provided information necessary to synthesize scFv
binders to IL-6 (31).
A proteomics approach that combines high resolution LC-
MS/MS analysis of purified and digested fragments of serum
antibodies referenced against databases derived from the NGS
reads of the B cell repertoire has been developed to provide
more precise information for VH:VL pairing (32). However, this
is a difficult problem to solve using proteomics because VH
and VL abundances do not correlate, due to an excess of VL
secreted into the serum, and the fact that VL sequences have
lower complexity which results in VL sequences sharing partial
identity (26).
Recently, an elegant solution to this problem has been
described, which isolated more than 5× 104 single B cells individ-
ually in the microwells of a high-density microplate (33). Poly-dT
beads were added to the wells and, after cell-lysis, the mRNA
was captured on the beads and emulsified for cDNA synthesis.
The VH:VL pairs were linked by PCR and sequenced by paired-
end long reads using Illumina technology. This experiment was
performed on repertoires post-immunization for antigen-specific
plasmablasts against tetanus toxoid and for memory B cells after
influenza vaccination. Some of the VH:VL pairs identified were
expressed in IgG format and they all demonstrated affinities in the
subnanomolar-nanomolar range.
APPLICATION OF NGS TO FUTURE ANTIBODY ENGINEERING
Antibody display libraries derived from human PBMCs or
hybridomas immortalized from B cell populations have been suc-
cessfully used in recent decades to isolate binders against a wide
range of targets, despite a lack of detailed knowledge of the reper-
toires (34, 35). With the advent of NGS, analysis of the natural
naïve repertoires from which libraries have been constructed has
become possible.
In an early paper, the diversity of a phage displayed combina-
torial library generated from the IgM repertoire of 654 healthy
human donors was precisely quantified by deep sequencing pre-
and post-selection using long-read pyrosequencing (12). Variable
domain PCR amplicon and rolling circle amplified shotgun meth-
ods allowed an efficient assessment of diversity, as well as the
correct assignment of heavy and light chain pairing. A novel appli-
cation of Hidden Markov Model (HMM) accurately identified
CDR regions. The sequencing results revealed that all germline
families were present and a high degree of somatic mutations in
CDR1 and CDR2 provided additional complexity to a library that
was estimated to be similar in diversity to the number of transfor-
mants (3.5× 1010). The library was subjected to panning against
16 targets and pairing preferences were observed for heavy and
light chains. This information was used to produce combinator-
ial libraries that mimic the natural repertoire both in length and
sequence diversity. A synthetic Fab library was fabricated in which
all six CDRs are diversified by synthetic enzymatic codon addi-
tion method allowing precise control of amino acid additions at
each position in the CDRs, to recapitulate those found in nature.
The library was subjected to panning against a diverse panel of
receptors, growth factors, antigens, enzymes, and peptides. Binders
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were isolated for all antigens with nanomolar affinities measured
for 6 out of 10 antigens (36).
Larman et al. (37) describe an interesting synthetic approach
where CDR sequences were designed using a HMM model of “con-
tact”and“non-contact”states for amino acid positions based upon
known antibody-antigen complexes. These sequences were syn-
thesized in a releasable format on a DNA microarray, assembled
into a single framework scFv library, panned by ribosome display
against poliovirus receptor-related 4 (PVRL4) and the binding
output submitted to NGS analysis. Of the top 25 most abun-
dant clones post-selection, four were found to specifically bind
human mammary epithelial cell (HMEC)-expressed PVRL4 by
FACS-staining analysis.
Further scrutiny of natural systems, the use of modern synthetic
approaches, surveying the enrichment process, and examining
the resulting targeted antibody repertoire will better inform the
design of next generation synthetic libraries (36, 38–40). This will
undoubtedly improve the performance of synthetic libraries, many
of which have been poor in functionality due to degenerate designs
that do not respect loop length diversity, amino acid, or structural
preferences of natural systems.
CONCLUSION
Major challenges still remain in the use of NGS for anti-
body research with respect to reliably identifying the heavy
and light chain pairs, as well as the bioinformatic analysis of
the output. However, in a relatively short time span, NGS has
impacted heavily on our understanding of the mechanism of
the humoral response to viral insult, antibody clonal selec-
tion, and the chemical and structural nature of the binding
landscape of the variable domains. Yet, whilst it has enabled
researchers to take small steps forward in the quest for deriv-
ing the ultimate binders from their systems, NGS methods also
highlight the need to learn more from both natural and syn-
thetic repertoires. Sequencing combined with proteomics tech-
niques will provide better resolution of the natural systems,
and modern library synthesis methodologies will allow greater
use of rational and combinatorial approaches. These will per-
mit scientists to create designer libraries that will specifically
address certain classes of antigens or determine greater biophys-
ical stability, manufacturability, longer shelf-life, and improved
pharmacokinetic and pharmacodynamics properties than existing
antibody therapeutics.
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